|
Uses and limitations of artificial intelligence for oncology
|
March 30, 2024
|
PC3I Authors Likhitha Kolla; Ravi Parikh |
Cancer
|
|
The case for AI-driven cancer clinical trials – The efficacy arm in silico
|
June 3, 2021
|
PC3I Authors Likhitha Kolla; Ravi Parikh |
Biochimica et Biophysica Acta. Reviews on Cancer
|
|
Application of Traditional Vaccine Development Strategies to SARS-CoV-2
|
August 29, 2022
|
PC3I Authors Likhitha Kolla |
ArXiv
|
|
The Coming of Age of Nucleic Acid Vaccines during COVID-19
|
October 20, 2022
|
PC3I Authors Likhitha Kolla |
ArXiv
|
|
Performance drift in a mortality prediction algorithm among patients with cancer during the SARS-CoV-2 pandemic
|
November 21, 2022
|
PC3I Authors Ravi Parikh; Likhitha Kolla |
Journal of the American Medical Informatics Association
|
|
Application of Traditional Vaccine Development Strategies to SARS-CoV-2
|
March 2, 2023
|
PC3I Authors Likhitha Kolla |
mSystems
|
|
The Coming of Age of Nucleic Acid Vaccines during COVID-19
|
March 2, 2023
|
PC3I Authors Likhitha Kolla |
mSystems
|
|
Time of Clinic Appointment and Serious Illness Communication in Oncology
|
April 18, 2023
|
PC3I Authors Likhitha Kolla; Ravi Parikh |
Cancer Control
|
